Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Seckl MJ"'
Autor:
Braga A; Rio de Janeiro Trophoblastic Disease Centre, Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University, Rio de Janeiro, Brazil; Postgraduate Program in Perinatal Health, Faculty of Medicine, Maternity School of Rio de Janeiro Federal University, Rio de Janeiro, Brazil; Postgraduate Program in Medical Sciences, Fluminense Federal University, Niterói, Brazil., Berkowitz RS; New England Trophoblastic Disease Centre, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Seckl MJ; Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial College Hospitals NHS Trust, London W6 8RF, UK. Electronic address: m.seckl@imperial.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Oct; Vol. 22 (10), pp. e421.
Autor:
Ngan HYS; Department of Obstetrics and Gynecology, University of Hong Kong, Queen Mary Hospital, Hong Kong, China., Seckl MJ; Department of Medical Oncology, Charing Cross Trophoblastic Disease Center, Charing Cross Campus of Imperial College London, London, UK., Berkowitz RS; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Xiang Y; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Golfier F; Department of Obstetrics and Gynecology, French Trophoblastic Disease Reference Centre, Lyon University Hospital, Claude Bernard Lyon 1 University, Lyon, France., Sekharan PK; Department of Obstetrics and Gynecology, Institute of Maternal and Child Health, Medical College, Calicut, India., Lurain JR; John I. Brewer Trophoblastic Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Massuger L; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands.
Publikováno v:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2021 Oct; Vol. 155 Suppl 1, pp. 86-93.
Autor:
Savage P; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Winter M; Sheffield Trophoblastic Disease Centre, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Parker V; Sheffield Trophoblastic Disease Centre, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Harding V; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Sita-Lumsden A; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Fisher RA; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Harvey R; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Unsworth N; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Sarwar N; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Short D; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Aguiar X; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK., Tidy J; Sheffield Trophoblastic Disease Centre, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hancock B; Sheffield Trophoblastic Disease Centre, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Coleman R; Sheffield Trophoblastic Disease Centre, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Seckl MJ; Department of Medical Oncology, Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial Hospitals NHS Trust, London, UK.
Publikováno v:
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2020 Aug; Vol. 127 (9), pp. 1102-1107. Date of Electronic Publication: 2020 Apr 03.
Autor:
Savage P; Trophoblastic Tumour Screening & Treatment Centre, Charing Cross Hospital Campus of Imperial College, London, UK. savage13561@msn.com.; BCCA, Victoria, BC, Canada. savage13561@msn.com., Monk D; Imprinting and Cancer Group, Cancer Epigenetic and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Hernandez Mora JR; Imprinting and Cancer Group, Cancer Epigenetic and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., van der Westhuizen N; BCCA, Victoria, BC, Canada., Rauw J; BCCA, Victoria, BC, Canada., Tinker A; BCCA, Victoria, BC, Canada., Robinson W; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada., Song Q; State Key Lab of Molecular Oncology, Laboratory of Cell and Molecular Biology, National Cancer Center, Beijing, China., Seckl MJ; Trophoblastic Tumour Screening & Treatment Centre, Charing Cross Hospital Campus of Imperial College, London, UK., Fisher RA; Trophoblastic Tumour Screening & Treatment Centre, Charing Cross Hospital Campus of Imperial College, London, UK.; Department of Surgery and Cancer, Imperial College , London, UK.
Publikováno v:
BMC cancer [BMC Cancer] 2019 Jul 29; Vol. 19 (1), pp. 744. Date of Electronic Publication: 2019 Jul 29.
Autor:
Earp KE; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK. Electronic address: kate.earp@sth.nhs.uk., Hancock BW; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Short D; Trophoblastic Disease Centre, Charing Cross Hospital, London, UK., Harvey RA; Trophoblastic Disease Centre, Charing Cross Hospital, London, UK., Fisher RA; Trophoblastic Disease Centre, Charing Cross Hospital, London, UK., Drew D; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Sarwar N; Trophoblastic Disease Centre, Charing Cross Hospital, London, UK., Tidy JA; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Winter MC; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Chien P; Trophoblastic Disease Centre, Ninewells Hospital, Dundee, UK., Seckl MJ; Trophoblastic Disease Centre, Charing Cross Hospital, London, UK.
Publikováno v:
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2019 Mar; Vol. 234, pp. 117-119. Date of Electronic Publication: 2019 Jan 06.
Autor:
Froeling FEM; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Ramaswami R; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Papanastasopoulos P; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Kaur B; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Sebire NJ; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Short D; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Fisher RA; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Sarwar N; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK., Wells M; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Singh K; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Ellis L; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Horsman JM; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Winter MC; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Tidy J; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Hancock BW; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK., Seckl MJ; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK. m.seckl@imperial.ac.uk.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Mar; Vol. 120 (6), pp. 587-594. Date of Electronic Publication: 2019 Feb 22.
Autor:
Coyle C; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom., Short D; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom., Jackson L; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom., Sebire NJ; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom., Kaur B; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom., Harvey R; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom., Savage PM; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom., Seckl MJ; Department of Cancer Medicine, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London W6 8RF, United Kingdom. Electronic address: m.seckl@imperial.ac.uk.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2018 Feb; Vol. 148 (2), pp. 254-257. Date of Electronic Publication: 2017 Dec 09.
Autor:
Ghorani E; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College London, London W6 8RF, UK; Cancer Immunology Unit, University College London Cancer Institute, London, UK., Kaur B; Department of Histopathology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College London, London W6 8RF, UK., Fisher RA; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College London, London W6 8RF, UK., Short D; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College London, London W6 8RF, UK., Joneborg U; Department of Women's and Children's Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Carlson JW; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Akarca A; Department of Cellular Pathology, University College London Hospital, London, UK., Marafioti T; Department of Cellular Pathology, University College London Hospital, London, UK., Quezada SA; Cancer Immunology Unit, University College London Cancer Institute, London, UK., Sarwar N; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College London, London W6 8RF, UK., Seckl MJ; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College London, London W6 8RF, UK. Electronic address: m.seckl@imperial.ac.uk.
Publikováno v:
Lancet (London, England) [Lancet] 2017 Nov 25; Vol. 390 (10110), pp. 2343-2345.
Autor:
Braga A; Trophoblastic Disease Center, Maternity School of Rio de Janeiro Federal University and Antonio Pedro University Hospital at Fluminense Federal University, Rio de Janeiro, Brazil.; Postdoctoral Program of Science without Borders (Brazilian Government) - Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College School of Medicine, London, UK.; Postdoctoral Program of Gynecology, Obstetrics and Mastology Postgraduate of Botucatu Medical School, UNESP- São Paulo State University, Botucatu, São Paulo, Brazil.; Trophoblastic Disease Center, Department of Gynecology and Obstetrics, Botucatu Medical School, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil., Maestá I; Trophoblastic Disease Center, Department of Gynecology and Obstetrics, Botucatu Medical School, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil., Short D; Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College School of Medicine, London, UK., Savage P; Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College School of Medicine, London, UK., Harvey R; Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College School of Medicine, London, UK., Seckl MJ; Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College School of Medicine, London, UK.
Publikováno v:
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2016 Jul; Vol. 123 (8), pp. 1330-5. Date of Electronic Publication: 2015 Oct 07.